These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 2399266)

  • 1. Comparative hematopoietic toxicity of doxorubicin and 4'-epirubicin.
    OKunewick JP; Kociban DL; Buffo MJ
    Proc Soc Exp Biol Med; 1990 Oct; 195(1):95-9. PubMed ID: 2399266
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative toxicity of mitoxantrone and doxorubicin on hematopoietic stem cells.
    OKunewick JP; Buffo MJ; Kociban DL
    Exp Hematol; 1985; 13 Suppl 16():23-30. PubMed ID: 3987836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intracellular uptake and cytotoxic effect in vitro of doxorubicin and epirubicin in human leukemic and normal hematopoietic cells.
    Tidefelt U; Sundman-Engberg B; Paul C
    Cancer Chemother Pharmacol; 1991; 29(1):7-12. PubMed ID: 1742852
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the activity of doxorubicin analogues using colony-forming assays and human xenografts.
    Taetle R; Howell SB; Giuliani FC; Koziol J; Koessler A
    Cancer; 1982 Oct; 50(8):1455-61. PubMed ID: 6956427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diltiazem does not increase the in vivo sensitivity of murine hemopoietic progenitor cells to doxorubicin.
    Lerza R; Bogliolo G; Saviane A; Mencoboni M; Pannacciulli I
    Life Sci; 1988; 42(6):651-8. PubMed ID: 3339952
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activity of doxorubicin linked to poly-L-aspartic acid on normal murine hematopoietic progenitor cells.
    Bogliolo G; Muzzulini C; Lerza R; Pannacciulli I
    Cancer Treat Rep; 1986 Nov; 70(11):1275-81. PubMed ID: 3768872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of cytokine treatment (granulocyte colony-stimulating factor and stem cell factor) on hematopoiesis and the circulating pool of hematopoietic stem cells in mice.
    Drize N; Chertkov J; Samoilina N; Zander A
    Exp Hematol; 1996 Jun; 24(7):816-22. PubMed ID: 8647232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mobilization of peripheral blood progenitor cells (PBPC) through a combination of chemotherapy and G-CSF in breast cancer patients and a possibility of unprocessed whole blood collection.
    Vanásek J; Filip S; Medková V; Bláha M; Mericka P; Volenec K
    Bone Marrow Transplant; 1998 Jan; 21(2):123-6. PubMed ID: 9489627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methods for measuring suppression of hematopoiesis.
    Chervenick PA
    Exp Hematol; 1985; 13 Suppl 16():8-15. PubMed ID: 3987838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of interleukin-1, GM-CSF, erythropoietin, and lithium on the toxicity associated with 3'-azido-3'-deoxythymidine (AZT) in vitro on hematopoietic progenitors (CFU-GM, CFU-MEG, and BFU-E) using murine retrovirus-infected hematopoietic cells.
    Gallicchio VS; Hughes NK; Hulette BC; Noblitt L
    J Leukoc Biol; 1991 Dec; 50(6):580-6. PubMed ID: 1940611
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leukopenia and altered hematopoietic activity in mice exposed to the abused inhalant, isobutyl nitrite.
    Soderberg LS; Flick JT; Barnett JB
    Exp Hematol; 1996 Jun; 24(7):848-53. PubMed ID: 8647236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant transforming growth factor beta 1 and beta 2 protect mice from acutely lethal doses of 5-fluorouracil and doxorubicin.
    Grzegorzewski K; Ruscetti FW; Usui N; Damia G; Longo DL; Carlino JA; Keller JR; Wiltrout RH
    J Exp Med; 1994 Sep; 180(3):1047-57. PubMed ID: 8064224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activity of 4'-epi-doxorubicin on normal hematopoietic precursor cells in mice.
    Sobrero A; Muzzulini C; D'Amore F; Bogliolo G; Massa G; Ghio R; Pannacciulli I
    Cancer Treat Rep; 1982 Dec; 66(12):2061-70. PubMed ID: 6958365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lithium and hematopoietic toxicity. II. Acceleration in vivo of murine hematopoietic progenitor cells (CFU-gm and CFU-meg) following treatment with vinblastine sulfate.
    Gallicchio VS
    Int J Cell Cloning; 1987 Mar; 5(2):122-33. PubMed ID: 3572050
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo and in vitro comparison of the short-term hematopoietic toxicity between hydroxyurea and trimidox or didox, novel ribonucleotide reductase inhibitors with potential anti-HIV-1 activity.
    Mayhew CN; Phillips JD; Greenberg RN; Birch NJ; Elford HL; Gallicchio VS
    Stem Cells; 1999; 17(6):345-56. PubMed ID: 10606163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of anthracycline cardiotoxicity with the model of isolated, perfused rat heart: comparison of new analogues versus doxorubicin.
    Pouna P; Bonoron-Adèle S; Gouverneur G; Tariosse L; Besse P; Robert J
    Cancer Chemother Pharmacol; 1995; 35(3):257-61. PubMed ID: 7805186
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute toxic effects of 3'-azido-3'-deoxythymidine (AZT) on normal and regenerating murine hematopoiesis.
    Scheding S; Media JE; Nakeff A
    Exp Hematol; 1994 Jan; 22(1):60-5. PubMed ID: 8282060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The median daily increment of leukocytes during hematopoietic recovery reflects the myeloid progenitor cell yield during leukapheresis in children.
    Emminger W; Emminger-Schmidmeier W; Höcker P; Gerhartl C; Kundi M; Gadner H
    Bone Marrow Transplant; 1990 Jun; 5(6):419-24. PubMed ID: 2369682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A functional assessment of the relative cardiotoxicity of adriamycin and epirubicin in the rat.
    Yeung TK; Simmonds RH; Hopewell JW
    Radiother Oncol; 1989 Jul; 15(3):275-84. PubMed ID: 2772255
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maitake beta-glucan MD-fraction enhances bone marrow colony formation and reduces doxorubicin toxicity in vitro.
    Lin H; She YH; Cassileth BR; Sirotnak F; Cunningham Rundles S
    Int Immunopharmacol; 2004 Jan; 4(1):91-9. PubMed ID: 14975363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.